eLife (May 2018)

An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups

  • Riley Perszyk,
  • Brooke M Katzman,
  • Hirofumi Kusumoto,
  • Steven A Kell,
  • Matthew P Epplin,
  • Yesim A Tahirovic,
  • Rhonda L Moore,
  • David Menaldino,
  • Pieter Burger,
  • Dennis C Liotta,
  • Stephen F Traynelis

DOI
https://doi.org/10.7554/eLife.34711
Journal volume & issue
Vol. 7

Abstract

Read online

N-methyl-d-aspartate receptors (NMDARs) are an important receptor in the brain and have been implicated in multiple neurological disorders. Many non-selective NMDAR-targeting drugs are poorly tolerated, leading to efforts to target NMDAR subtypes to improve the therapeutic index. We describe here a series of negative allosteric NMDAR modulators with submaximal inhibition at saturating concentrations. Modest changes to the chemical structure interconvert negative and positive modulation. All modulators share the ability to enhance agonist potency and are use-dependent, requiring the binding of both agonists before modulators act with high potency. Data suggest that these modulators, including both enantiomers, bind to the same site on the receptor and share structural determinants of action. Due to the modulator properties, submaximal negative modulators in this series may spare NMDAR at the synapse, while augmenting the response of NMDAR in extrasynaptic spaces. These modulators could serve as useful tools to probe the role of extrasynaptic NMDARs.

Keywords